FDA OK's peripheral T-cell lymphoma drug
Monday, September 28, 2009 - 07:49
in Health & Medicine
WASHINGTON, Sept. 28 (UPI) -- The U.S. Food and Drug Administration has approved Folotyn as the first treatment for a form of cancer known as peripheral T-cell lymphoma.